Discover opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Sep 9, 2024 to Sep 9, 2024
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| National Institutes of Health Niaid | Battelle Memorial Institute | Sep 9, 2024 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES
Effective Date
Sep 17, 2021
Expires
Effective: Sep 17, 2021
PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES
ActiveNATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASE (NIAID), DIVISION OF INTRAMURAL RESEARCH (DIR), LABORATORY OF INFECTIOUS DISEASE (LID), VALIDATING INFLUENZA VACCINE CANDIDATES WITH A BSL3 MOUSE CHALLENGE MODE
Effective Date
Sep 13, 2024
Expires
NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASE (NIAID), DIVISION OF INTRAMURAL RESEARCH (DIR), LABORATORY OF INFECTIOUS DISEASE (LID), VALIDATING INFLUENZA VACCINE CANDIDATES WITH A BSL3 MOUSE CHALLENGE MODE
ActiveNATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), UNIVERSAL INFLUENZA VACCINE, PHASE II CLINICAL TRIAL, SUPPORT SERVICE
Effective Date
Sep 18, 2023
Expires
NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), UNIVERSAL INFLUENZA VACCINE, PHASE II CLINICAL TRIAL, SUPPORT SERVICE
ActiveNATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), DIVISION OF INTRAMURAL RESEARCH (DIR), VACCINE RESEARCH CENTER (VRC), LEADERSHIP AND INCLUSIVE EXCELLENCE PROGRAMMING
Effective Date
Jul 25, 2024
Expires
NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), DIVISION OF INTRAMURAL RESEARCH (DIR), VACCINE RESEARCH CENTER (VRC), LEADERSHIP AND INCLUSIVE EXCELLENCE PROGRAMMING
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →